BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20497585)

  • 1. Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9.
    Mathews JD; McBryde ES; McVernon J; Pallaghy PK; McCaw JM
    BMC Infect Dis; 2010 May; 10():128. PubMed ID: 20497585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations.
    Chowell G; Viboud C; Simonsen L; Miller MA; Acuna-Soto R
    J Infect Dis; 2010 Aug; 202(4):567-75. PubMed ID: 20594109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geography may explain adult mortality from the 1918-20 influenza pandemic.
    Mamelund SE
    Epidemics; 2011 Mar; 3(1):46-60. PubMed ID: 21420659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies.
    Andreasen V; Viboud C; Simonsen L
    J Infect Dis; 2008 Jan; 197(2):270-8. PubMed ID: 18194088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning for the next influenza H1N1 season: a modelling study.
    Carrat F; Pelat C; Levy-Bruhl D; Bonmarin I; Lapidus N
    BMC Infect Dis; 2010 Oct; 10():301. PubMed ID: 20964814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding influenza transmission, immunity and pandemic threats.
    Mathews JD; Chesson JM; McCaw JM; McVernon J
    Influenza Other Respir Viruses; 2009 Jul; 3(4):143-9. PubMed ID: 19627371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity.
    Mathews JD; McCaw CT; McVernon J; McBryde ES; McCaw JM
    PLoS One; 2007 Nov; 2(11):e1220. PubMed ID: 18043733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift.
    Saglanmak N; Andreasen V; Simonsen L; Mølbak K; Miller MA; Viboud C
    Vaccine; 2011 Jul; 29 Suppl 2(Suppl 2):B42-8. PubMed ID: 21757103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of changing host immunity on 1918-19 pandemic dynamics.
    Bolton KJ; McCaw JM; McVernon J; Mathews JD
    Epidemics; 2014 Sep; 8():18-27. PubMed ID: 25240900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic.
    Hsieh YH; Huang HM; Lan YC
    PLoS One; 2016; 11(5):e0154695. PubMed ID: 27139905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intense seasonal A/H1N1 influenza in Mexico, winter 2013-2014.
    Dávila-Torres J; Chowell G; Borja-Aburto VH; Viboud C; Grajalez-Muñiz C; Miller MA
    Arch Med Res; 2015 Jan; 46(1):63-70. PubMed ID: 25446618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.
    Paulo AC; Correia-Neves M; Domingos T; Murta AG; Pedrosa J
    PLoS One; 2010 Jul; 5(7):e11655. PubMed ID: 20668679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?
    Allwinn R; Geiler J; Berger A; Cinatl J; Doerr HW
    Med Microbiol Immunol; 2010 May; 199(2):117-21. PubMed ID: 20162304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.
    Epstein SL
    J Infect Dis; 2006 Jan; 193(1):49-53. PubMed ID: 16323131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
    Wu JT; Ma ES; Lee CK; Chu DK; Ho PL; Shen AL; Ho A; Hung IF; Riley S; Ho LM; Lin CK; Tsang T; Lo SV; Lau YL; Leung GM; Cowling BJ; Malik Peiris JS
    Clin Infect Dis; 2010 Nov; 51(10):1184-91. PubMed ID: 20964521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical immune and vaccination thresholds for determining multiple influenza epidemic waves.
    Matrajt L; Longini IM
    Epidemics; 2012 Mar; 4(1):22-32. PubMed ID: 22325011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.